⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22109497 | 0.80 | — | — | |
| SCHEMBL25012061 | 0.60 | — | — | |
| SCHEMBL20937511 | 0.56 | — | — | |
| SCHEMBL22081666 | 0.55 | — | — | |
| SCHEMBL24033602 | 0.54 | — | — | |
| SCHEMBL24033601 | 0.54 | — | — | |
| SCHEMBL24533972 | 0.54 | — | — | |
| SCHEMBL23562238 | 0.53 | — | — | |
| SCHEMBL24931210 | 0.53 | — | — | |
| SCHEMBL24186984 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3191483-B1 | COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF | NORTH & SOUTH BROTHER PHARMACY INVESTMENT CO LTD (CN) | 2020-06-10 | — | — | EP | disclosed |